In addition to the loss of spinal motor neurons, amyotrophic lateral sclerosis (ALS) is also associated with degeneration of corticospinal layer V pyramidal neurons and decreased glutamate transport in the cortex. We characterized the glutamate receptors on corticospinal neurons in acutely isolated rat motor cortex slices and found that the synaptic inputs to the corticospinal layer V neurons had a lesser proportional contribution from NMDA receptors relative to AMPA receptors than did layer II/III pyramidal neurons. The synaptic I AMPA was also more inwardly rectified, indicating a greater Ca 2+ -permeable component, in layer V. In a cortical organotypic slice culture model, blockade of glutamate transporters elevated glutamate in the media and led to pyramidal neuron loss in both layers. The loss of layer V pyramidal neurons was attenuated by antagonists of AMPA/kainate or Ca 2+ -permeable AMPA receptors, suggesting their therapeutic potential in the protection of the motor cortex in ALS.
Introduction
In the motor cortex of amyotrophic lateral sclerosis (ALS) patients, corticospinal layer V pyramidal neurons (upper motor neurons) are progressively lost during the course of the disease. Loss of layer II/III pyramidal neurons also occurs in the severe disease stages (Nihei et al., 1993) . Decreased astrocytic glutamate uptake and elevated glutamate concentrations in the cerebrospinal fluid (CSF) suggest that the neuronal toxicity may be mediated by excess glutamate (Rothstein et al., 1990 (Rothstein et al., , 1992 (Rothstein et al., , 1995 . While the N-methyl-D-aspartate (NMDA) receptor subtype may mediate acute glutamate excitotoxicity of dissociated cortical neurons (Weiss et al., 1990) , it is not known whether the non-NMDA or NMDA receptor subtypes contribute to loss of cortical pyramidal neurons in ALS.
Different α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor properties may explain the selective vulnerability of spinal motor neurons to excitotoxicity in ALS (Vandenberghe et al., 2000a,b; Van Damme et al., 2002; Kawahara et al., 2004) . In particular, Ca 2+ -permeable AMPA receptors, lacking edited GluR2 subunits, have been implicated in some of these studies. It is not known which glutamate receptor subtypes are expressed on upper motor neurons, nor has the role of Ca 2+ -permeable AMPA receptors in upper motor neuron disease been established. We therefore set out to investigate both the relative proportion of synaptic NMDA versus AMPA receptors and the Ca 2+ permeability properties of synaptic AMPA receptors in upper motor neurons using acute rat brain slices.
For study of disease mechanisms in spinal motor neurons, glutamate transport inhibitors have been successfully used to generate a slow toxicity model in rat spinal cord organotypic cultures (Rothstein et al., 1993) or in vivo, by intrathecal infusion (Hirata et al., 1997) . Because it generates long-term low-level glutamate toxicity, blocking glutamate uptake is more likely to resemble the ALS disease process than are acute toxicity models. No reports have described chronic toxicity induced by glutamate transport inhibitors in cortical organotypic cultures. In dissociated mixed neuronal/glial murine cortical cultures, the application of the glutamate uptake inhibitor trans-4-carboxy-L-proline (PDC) for up to 24 h produced neuronal loss without loss of glial cells that correlated with increased glutamate concentrations and was prevented by NMDA antagonists but not AMPA/kainate antagonists (Velasco et al., 1996) .
To specifically study the large layer V pyramidal neurons in tissue maintaining its structural organization, an organotypic culture model of rat motor cortex was developed (Van Westerlaak et al., 2001a) . Neuronal death induced by two-week treatment with the mitochondrial toxin malonate was inhibited by either NMDA or AMPA/kainate antagonists. Riluzole, a glutamate release inhibitor, was also neuroprotective under these conditions (Van Westerlaak et al., 2001b) . However, the effect on cortical pyramidal neurons of chronically elevated glutamate levels is unknown. In the present study, we used patch clamp electrophysiology to characterize glutamate receptor expression in pyramidal neurons in acute cortical slices from young adult rats and applied an organotypic motor cortex slice culture model to assess the receptor subtypes mediating pyramidal neuron toxicity due to chronically elevated glutamate. 
